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Abstract
Background: Recent developments have made screening tests for foetal abnormalities available earlier
in pregnancy and women have a range of testing options accessible to them. It is now recommended that
all women, regardless of their age, are provided with information on prenatal screening tests. General
Practitioners (GPs) are often the first health professionals a woman consults in pregnancy. As such, GPs
are well positioned to inform women of the increasing range of prenatal screening tests available. The aim
of this study was to explore GPs experience of informing women of prenatal genetic screening tests for
foetal abnormality.
Methods: A qualitative study consisting of four focus groups was conducted in metropolitan and rural
Victoria, Australia. A discussion guide was used and the audio-taped transcripts were independently coded
by two researchers using thematic analysis. Multiple coders and analysts and informant feedback were
employed to reduce the potential for researcher bias and increase the validity of the findings.
Results: Six themes were identified and classified as 'intrinsic' if they occurred within the context of the
consultation or 'extrinsic' if they consisted of elements that impacted on the GP beyond the scope of the
consultation. The three intrinsic themes were the way GPs explained the limitations of screening, the
extent to which GPs provided information selectively and the time pressures at play. The three extrinsic
factors were GPs' attitudes and values towards screening, the conflict they experienced in offering
screening information and the sense of powerlessness within the screening test process and the health
care system generally. Extrinsic themes reveal GPs' attitudes and values to screening and to disability, as
well as raising questions about the fundamental premise of testing.
Conclusion: The increasing availability and utilisation of screening tests, in particular first trimester tests,
has expanded GPs' role in facilitating women's informed decision-making. Recognition of the importance
of providing this complex information warrants longer consultations to respond to the time pressures that
GPs experience. Understanding the intrinsic and extrinsic factors that impact on GPs may serve to shape
educational resources to be more appropriate, relevant and supportive.
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Background
Recent developments have made screening tests for foetal
abnormalities available earlier in pregnancy and women
have a range of testing options accessible to them. It is
now recommended that all women, regardless of their
age, are provided with information on prenatal screening
tests [1,2]. The provision of information is an essential
component in facilitating women's informed decision-
making [3-6]. At a minimum, women need to understand
the condition(s) for which the testing is being offered, the
characteristics of the test and the implications of testing
[4].
Health professionals need to provide women with infor-
mation on both the benefits and inherent limitations of
screening tests in a way that optimises understanding,
without increasing their level of anxiety [7-9]. This is par-
ticularly true of tests screening for foetal abnormality
where decisions on diagnostic testing and/or termination
of an affected pregnancy may arise.
The quality of information women have received has been
found to be variable [4], while women have consistently
demonstrated low levels of knowledge about prenatal
screening for foetal abnormalities [3,5,6,10-13]. Conse-
quently, there are challenges for all pregnancy care provid-
ers as well as implications for practice.
The introduction of screening tests in the first trimester of
pregnancy has resulted in extending the role of General
Practitioners (GPs). When providing confirmation of
pregnancy, GPs are often the first health professional the
woman consults. If this is in the first trimester, women are
more likely to have all the prenatal test options available
and have time to consider the information provided. As a
primary health care provider the GP is well positioned to
inform women of the increasing range of screening tests
available.
Women value quality information that is provided by the
health professional in a timely manner [14]. This requires
the health professional to have a sound understanding of
the relevant issues and be able to communicate this infor-
mation. While studies have focused on exploring the
knowledge and attitudes of health professionals towards
prenatal testing [15-18], the effect on health professionals
of providing this information to women has not received
much attention. The purpose of this study was to explore
GPs' experience of informing women about prenatal
genetic screening tests for foetal abnormality.
Methods
The study was conducted to inform the development of a
decision aid for prenatal testing for foetal abnormalities,
as part of a randomised controlled trial called the ADEPT
(A DEcision aid for Prenatal  Testing) study
[ISRCTN22532458] [19,20].
Focus groups interviews were used in preference to indi-
vidual interviews as the synergistic effects of a group set-
ting may result in the production of ideas that might not
have been uncovered in individual interviews [21]. Purpo-
sive sampling [22] was employed to ensure both male and
female GPs from rural and metropolitan practices partici-
pated, thereby increasing the heterogeneity of experiences
and perspectives. Contact details were obtained from the
on-line public telephone listings and GPs from targeted
geographical areas were invited to participate in the study.
GPs were also recruited from a variety of professional
medical organisations. The team of investigators was com-
prised of a midwife (CN), an associate genetic counsellor
(SL), a psychologist (BM), a general practitioner (JG) and
two epidemiologists (JH and RB).
Informational redundancy was reached following four
focus groups and no further groups were conducted in
accordance with standard qualitative methodology [22].
The same facilitator (SL) and co-facilitator (CN) con-
ducted all focus groups, using a semi-structured discus-
sion guide to explore GPs' experiences. A literature review
and the expertise of the project team informed the content
of the question topics. The development of the discussion
guide (Appendix) was informed by the method outlined
by Greenwood and Parsons [23]. Audio-tapes of the ses-
sions were professionally transcribed and the accuracy of
the transcripts was verified using the raw data and field
notes.
The analysis involved a constant comparison approach
[24], with SL and CN repeatedly reading the transcripts to
develop an agreed set of codes. The analysis was also
guided by the conceptual qualitative research framework
of Miles and Huberman [25]. One of the strengths of this
framework lies in the explicitness of its description of
qualitative data analysis, which includes the use of highly
structured data displays to tease out relationships, synthe-
sise findings and help guide against potential researcher
bias. Data analyses were iterative and SL, RB & CN partic-
ipated in this process to identify and agree upon emergent
themes and discuss their face validity. The analysis took
place concurrently with data collection, and results from
each focus group were used to suggest additional lines of
questioning in subsequent focus groups to ensure that
divergent points of view would be expressed. The use of
multiple coders and analysts and informant feedback are
strategies recommended by Miles and Huberman to
reduce the potential for researcher bias and increase the
validity of the findings [25]. A draft manuscript was
reviewed by four GPs who participated in different groups
to authenticate the findings as representative of discus-BMC Health Services Research 2008, 8:114 http://www.biomedcentral.com/1472-6963/8/114
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sions and modify accordingly. In addition, a modified
version of the clustered matrices described by Miles and
Huberman [25] was used to facilitate analysis within and
across groups. A code was used to de-identify responses
comprising of a sequence of two digit codes for the group
and the participant. Ethics approval was obtained from
the Royal College of General Practitioners, Australia (ref
NREEC 03-16) to conduct the study. All participants pro-
vided written consent to participate in the study.
Results
Two groups were held in metropolitan locations and two
in regional settings in Victoria, one of the south-eastern
states of Australia, where approximately 63,000 women
give birth each year [26]. In Australia the GP's role can
vary from, at a minimum, confirming pregnancy and pro-
viding referral, to sharing pregnancy care with another
provider (midwife, obstetrician) through to providing
care in labour and the postnatal period. Prenatal care
arrangements vary in different Australian States; in Victo-
ria, women booked to give birth at publicly funded mater-
nity services have access to a second trimester maternal
serum screening test free of charge. Women in the public
system who are at increased risk of foetal abnormality on
the basis of their screening test result or their age (37 years
or older by expected due date), are offered a funded diag-
nostic test at a tertiary hospital. Other screening tests,
including nuchal translucency, combined first trimester
screening and second trimester foetal anomaly ultra-
sounds, as well as diagnostic tests are available to all
women on a fee for service basis.
In total twenty-seven GPs expressed interest and all partic-
ipated: 18 female and 9 male. Six themes important in
understanding GPs' experiences of informing women
about screening tests were identified as common across
the four groups. The themes were conceptualised as either
intrinsic or extrinsic factors. Intrinsic factors describe the
elements within the context of the consultation that
impact on GPs. Extrinsic factors describe elements that
operate beyond the scope of the consultation and have a
broader impact on GPs. To further illustrate these six
themes, the roles GPs adopt in response to both intrinsic
and extrinsic factors are detailed in Table 1.
Intrinsic Factors
Three factors occurring within the context of the consulta-
tion were consistently evident across all groups when the
topic of screening was first broached by the GP. First, the
limitations of screening was a central intrinsic factor.
Another was the extent to which GPs filtered the complex
information, and how they facilitated decision-making
based on their own perceptions of the woman's informa-
tion needs. The third related to time constraints, which
was a pervasive factor across all aspects of communicating
screening test information.
Limitations of screening
In order to inform women of screening tests, GPs related
difficulties in communicating the complex information
about the limitations of screening to women. Quotes to
illustrate these views are shown in Table 2. All GPs
reported presenting numerical expressions of probability
in a way that was meaningful, particularly as there was
strong agreement that women generally had a poor under-
standing of statistics.
Communicating the inherent limitations of screening
tests to the woman was reported as being a challenging
experience for GPs. For many GPs, central to interpreting
this complex information for women was the issue of
grappling with the notions of risk and uncertainty, which
challenged GPs on a number of levels. Not being able to
provide a definitive answer was perceived as being a par-
ticularly difficult task. For some GPs, screening test discus-
sions exposed their own lack of confidence or skill in
dealing with screening test information. Providing a pre-
test probability that was meaningful and conveying that a
residual risk would exist, without causing anxiety, were
also identified as difficulties.
Selectivity
GPs identified themselves as an important source of
screening test information for the woman. There was con-
siderable variation in the amount, level and delivery of
information on screening tests that GPs provided. From
the transcripts it was evident that many GPs provided
information to women selectively, based on their percep-
tions of the woman's information needs, as well as the
decision-making style they used within the consultation.
Acting as the 'gatekeeper of information', GPs demon-
strated how testing can be presented differently to
women, usually on the basis of maternal age or parity
(Table 3). This was a deliberate process on the part of
some GPs, yet for others it appeared to occur unintention-
ally. Some GPs who could be classified as providing infor-
Table 1: Conceptual framework for understanding the impact of 
GPs' role in informing women of prenatal screening tests
Factors Role of the GP
Intrinsic Factors
1. Limitations of screening Interpreter
2. Selectivity Gatekeeper
3. Time pressures Timekeeper
Extrinsic Factors
4. Potential sequelae Bearer of bad news
5. Conflict Moral agent
6. Shifting sands IntermediaryBMC Health Services Research 2008, 8:114 http://www.biomedcentral.com/1472-6963/8/114
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mation selectively to women also appeared to use a
directive style within the consultation. GPs who indicated
they communicated using a less directive decision-making
style and involved the woman in decision-making,
appeared less likely to act in a gatekeeper role.
When asked who tended to raise the issue of prenatal test-
ing, seldom was the provision of screening information
explained in terms of being at the woman's initiation.
When women did raise the issue of testing, it was often
explained in terms of women asking for the GP's personal
recommendation, "...that's a question I commonly get asked
– what would I do?" 0204
Time pressures
GPs described time pressures related to informing women
about prenatal testing for foetal abnormalities as a signif-
icant source of stress. Time constraints were experienced
because of the limitations of screening, the need for the
information to be provided early in pregnancy and the
competing pregnancy-related information the GP wanted
to provide to the woman (quotes shown in Table 4). The
first consultation in pregnancy was described as being
information-laden and the discussions about testing
increased time pressures.
The GP was seen as being required to act as a 'timekeeper'
because screening test information was said to take a con-
siderable amount of time to explain. Consistently GPs
related that they had insufficient time to cover the topic
and that it required an entire consultation, but seldom
was this possible.
The introduction of first trimester screening tests has
meant that it is often not appropriate for the GP to defer a
discussion of these tests. GPs described how this impera-
tive of time had negative consequences for the woman
and themselves.
Extrinsic Factors
The following three factors have been classified as extrin-
sic as they consist of elements that impact on the GP,
beyond the scope of the consultation. They reveal GPs'
attitudes and values to screening and to disability, as well
as raising questions about the fundamental premise of
testing. Extrinsic factors also include perceptions by GPs
of their role within the screening test process and the
health care system generally.
Potential sequelae
In providing information about screening tests to women,
GPs voiced the importance of addressing why the tests
were being offered and the possible consequences of hav-
ing a screening test. GPs identified the negative impact on
GPs of providing this information earlier in pregnancy
than was required previously when women presented,
happy with the confirmation of their pregnancy, and the
GP needed to introduce the topic of testing (Table 5).
The GP was cast in the role of the 'bearer of bad news'
through introducing the topic of testing which included
the risk of foetal abnormality, the limitations of screening,
the role of diagnostic testing and the option of termina-
tion of pregnancy in the event of a major abnormality.
Table 2: Limitations of screening: The GP as the interpreter
"You can't leave it and say "Well we'll just do the screening and then shall we think about should we have an amnio." I think you have to actually give 
people an idea of what to expect before you even embark on this whole thing." 0109
"I think you've got to tell them that the test is not 100% and that's where I think it gets complicated – and that's where you've got difficulties with 
people who can't understand statistics -I can't even understand it." 0201
"Bottom line is there are no guarantees for anything. " 0108
"We should be explaining the greyness...... there's almost nothing that we can offer and almost nothing we can do, will have an absolutely definite 
black or white answer." 0109
"It needs to be made clear that the result is not foolproof -it's not absolute." 0103
"It's very hard to get that message through until they get the gold standard answer." 0301
Table 3: Selectivity: GP as the gatekeeper
"I certainly bring it up with everybody and give the various options that are available and I suppose I tend to push depending on what age that the 
mothers are." 0305
"If they're old I'll tell them I want you to think about it – if they're young, the subject is raised and then come back. And they often don't come 
back." 0204
"I think it's not good for doctors to assume just because someone's younger they wouldn't be interested or just because someone's old they would 
be interested, and to try and find the right language for that is quite challenging." 0404
"I still don't think women are going to understand what's best for them – they're going to rely on you to tell them what you think is best for them." 
0203
"I think we can only guide the patients to the best decision that they are going to be comfortable with." 0304BMC Health Services Research 2008, 8:114 http://www.biomedcentral.com/1472-6963/8/114
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Conflict
The apparent moral obligation to provide information on
screening tests was in conflict with the GPs' perceptions of
screening tests as having potentially negative implications
for the woman, society and themselves (Table 6). The
inherent limitations of a population screening approach
further exposed this conflict. In their role as the 'moral
agent', providing information on testing and offering the
tests was identified by some GPs as having the potential to
do more harm than good.
GPs related a concern for women who would be made
unduly anxious about the possibility of foetal abnormal-
ity. This was particularly true for young women where "a
very large number" of young women would be "put
through the anxiety" (0303) of testing for a single woman
to benefit.
GPs in the role of the 'moral agent' were also concerned
with the difficulty of "taking into account someone's own eth-
ical or moral perspective"(0404). Using language that did
not bring a personal value system into the consultation
was viewed as troublesome.
The provision of information to women on screening tests
caused some GPs to question how disability was being
valued in society and whether or not they were implicated
in promoting the 'perfect child'.
Shifting sands
GPs expressed issues of powerlessness relating to how
they viewed their role in the screening process (Table 7).
In part this was related to a difficulty in accessing and
keeping up-to-date with testing information. This was dis-
cussed in terms of the demands of their generalist work-
load, numerous recent developments in screening as well
as being up-to-date with practical aspects like cost and the
quality of local testing providers.
GPs in the role of the 'intermediary' described themselves
as acting as an advocate for the women, trying to empower
them to make an informed choice regarding testing and
avoid being coerced into testing by obstetricians who may
present testing as "routine" or "compulsory".
GPs also described the frustration of poor communication
from other health care providers and from problems with
the screening system particularly in offering screening
tests to women who are "not fully informed."
Discussion
The findings of our study expose the considerable impact
that informing women of prenatal screening tests for foe-
tal abnormality has on GPs. The identification of intrinsic
and extrinsic factors present a framework of describing the
observed differences between factors that are contained
within the consultation and factors that have a more per-
vasive impact on the GP. The consistency of the findings
across different focus groups underscores the salience of
the experience of GPs described. We propose that in order
to improve women's capacity to make an informed deci-
sion about screening, attention needs to be directed to
better support the GP's role.
The impact on GPs that we have described is only partially
explained by their lack of knowledge. In particular,
responsive professional development activities need to be
directed to the complexity of factors impacting on the GP
experience. Educational activities that embrace intrinsic
factors should include epidemiological content and focus
on communicating complex issues like 'risk' and 'uncer-
tainty'[27]. A framework such as the patient-centred clini-
cal method [28] within an interactive learning
environment could provide the opportunity for GPs to
explore ways to 'find common ground' in decision-mak-
ing and be less directive in the information they provide.
Table 4: Time pressures: GP as the Time keeper
"I give them written information on the first visit but I usually stress out that...time will run out, so if they don't actually make up their mind 
reasonably quickly..." 0103
"I didn't used to bring up screening, but now because there's a bit of pressure...timing for the tests. I do I just say are you interested in screening?" 
0202
"it's a lot to go through.... not to eat various foods, and you've got to tell them not to tell the world due to the risk of miscarriage, and you've got 
to tell them they can't have any alcohol and there's a lot to go through so it's fitting it all in." 0303
"To really discuss things in a meaningful way and give them information that they need to make a valid decision does become a fairly lengthy 
process." 0305
" it's very time-consuming to try and go through the issues when they first walk in..." 0404
Table 5: Potential sequelae: GP as the bearer of bad news
"I found it quite a downer. I mean they're all so excited about being 
pregnant and then within minutes we're talking about let's do a test to 
find out if you might need to terminate this pregnancy." 0304
"A lot would come in, they're overjoyed to be pregnant... and the 
thought of them throwing in testing for all those things that might be 
wrong with the pregnancy. It's a bit of a downer." 0103
"...In fact you feel like a bit of a spoilsport bringing it up because 
they're really happy and you know- and then your sort of saying Oh 
well you know I hate to bring it up but, have you thought about..." 
0405BMC Health Services Research 2008, 8:114 http://www.biomedcentral.com/1472-6963/8/114
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GPs already work within significant time constraints.
Other health professionals have previously reported the
intrinsic factor 'time pressures' experienced by GPs in our
study when informing women of screening [29,30]. The
number of options for prenatal testing and the availability
of earlier tests make extra demands on the GP's already
limited time. The lack of time available to discuss prenatal
testing is at odds with the increasing importance of the
GP's role in informing women of screening. With the uti-
lisation of prenatal screening increasing [31], it is timely
to consider how to increase the amount of time allocated
to consultations in early pregnancy. One option applica-
ble to the Australian health care system might be to fund
these complex discussions as long consultations, which
attract a higher Medicare (Australia's publicly-funded uni-
versal health care system) rebate.
Extrinsic factors that impact on the GP beyond the scope
of the consultation also warrant consideration. Our find-
ings indicate the importance of GPs' values and attitudes
to tests, screening and disability, in explaining how they
experience their role in informing women. It is important
that educational activities acknowledge and embrace the
range of values and attitudes that exist. It may also be ben-
eficial to consider creating forums for peer discussions
about challenging experiences.
Even in a group practice, GPs often function in an isolated
manner with limited opportunity to discuss issues relating
to consultations. For example, during one focus group a
GP revealed a professional concern to the group that the
GP had not talked about previously to anyone. In light of
the difficulties experienced by GPs in this study, a mecha-
nism for GPs to share and reflect on their experiences may
prove beneficial. For instance, the experience of genetic
counsellors promote the benefit of 'supervision' [32], sup-
porting the professional and providing a non-threatening
environment to discuss psychosocial aspects of consulta-
tions.
Conclusion
The purpose of using a qualitative design to address this
research question was to document the range of GP expe-
riences to facilitate an in depth analysis of issues in the
hope that these finding will make a valuable contribution
to achieving a better understanding of GPs' experience of
screening. However, only quantitative studies can unpack
the  degree  to which these experiences and beliefs are
endorsed.
This study provides a lens through which to view complex
primary health consultations. Facilitating women's
informed decision-making regarding prenatal screening
tests requires much more from the GP than the provision
of appropriate information under significant time con-
straints; moral dimensions also exert an influence.
An understanding of epidemiological language and com-
munication skills is needed by GPs to assist them in pro-
viding women with meaningful information. However, it
is important that the scope of future educational pro-
grams is broader than solely providing GPs with informa-
tion and education. Consideration of GPs' values and
attitudes may well serve to make educational resources
more appropriate, relevant and supportive. Educational
activities that fail to explore attitudes and values of partic-
ipants to disability, screening and termination of preg-
nancy may be considered fundamentally flawed.
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Table 6: Conflict: The GP as a moral agent
"I find it quite hard to be scientific and disconnected about it and yet still also taking into account someone's you know, value system." 0404
"You know some of them actually have the idea that because you're testing for it you've got to do something to fix it and they don't realize that 
there isn't anything you can do but terminate or decide to go through with the pregnancy." 0107
"What is meaningful information ?- even what is spina bifida really? and what is Down syndrome?.. are you going to terminate someone who has a 
great personality and a reasonably happy life? There are lots of issues...promoting...the perfect life, the perfect child, the perfect outcome whether 
we should you know – all those kind of things." 0202
"The other trick with that though is the perception of some people that it's not a risk – that it's alright to have a baby with a disability and therefore 
you know, how do you quantify that it's a risk you know... so how do you identify someone like that and not you know um, stir them up or upset 
them. It's tricky." 0404
Table 7: Shifting sands: GP as the intermediary
"There's been such massive changes in the last few years it's been hard to keep up with." 0306
"I still have some trouble on keeping up with what the changes are..." 0106
"It's not all that long ago that you tested after 37.5 years as a due date and under that you didn't sort of offer it and then it all sort of changed and 
now the lawyers have marched in and we now have to offer it everybody." 0303
"There's many pieces of information, but we can't all have a handle on because the ground's shifting, the tests are changing fairly rapidly.." 0304BMC Health Services Research 2008, 8:114 http://www.biomedcentral.com/1472-6963/8/114
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Appendix: discussion guide for focus groups
When I say the words "prenatal testing for Down syn-
drome", what is the first thing that comes into your mind?
Generally, how much do you think GPs know about pre-
natal testing?
How often does prenatal testing come up as a topic for
discussion during your consultations with pregnant
women?
Do you raise the issue of prenatal testing with pregnant
women or do they tend to bring it up?
How do you go about discussing prenatal testing with
pregnant women?
What questions do women commonly ask you about pre-
natal testing?
How much time do you spend in discussing prenatal test-
ing with women?
Tell me about your recent experiences discussing prenatal
testing with your patients.
What do you find most difficult about discussing prenatal
testing?
What are the key points about prenatal testing that you
think women need to understand in order to make a deci-
sion about what is best for them?
What resources do you use to discuss prenatal testing and
how helpful are they?
Are there other resources that you use for other health
related matters that you commonly use that you find use-
ful?
When do you think would be the best time to discuss pre-
natal testing and hand out a decision aid?
Are there any other issues that you would like to raise?
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